Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort [Phase 4]

View source ↗

Summary

Phase 4 trial update on supplementation with polyunsaturated fatty acids and antioxidants for contact lens discomfort; the study was terminated and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PUFAs and antioxidants supplementation (polyunsaturated fatty acids and antioxidants)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Dry Eye, Contact Lens Complication | Phase 4 | Status: TERMINATED | Results posted: 2025-03-06